BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36900310)

  • 1. Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS).
    Bielack SS; Kager L; Kühne T; Langer T; Reichardt P; Blattmann C; Kevric M; Mettmann V; Sorg B; Hecker-Nolting S
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.
    Fuchs N; Bielack SS; Epler D; Bieling P; Delling G; Körholz D; Graf N; Heise U; Jürgens H; Kotz R; Salzer-Kuntschik M; Weinel P; Werner M; Winkler K
    Ann Oncol; 1998 Aug; 9(8):893-9. PubMed ID: 9789613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    Bielack SS; Kempf-Bielack B; Heise U; Schwenzer D; Winkler K
    J Clin Oncol; 1999 Apr; 17(4):1164. PubMed ID: 10561175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International collaboration is feasible in trials for rare conditions: the EURAMOS experience.
    Marina N; Bielack S; Whelan J; Smeland S; Krailo M; Sydes MR; Butterfass-Bahloul T; Calaminus G; Bernstein M
    Cancer Treat Res; 2009; 152():339-53. PubMed ID: 20213400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years].
    Bielack S; Beck J; Delling G; Gerein V; Grümayer R; Hiddemann W; Jobke A; Jürgens H; Kornhuber G; Kotz R
    Klin Padiatr; 1989; 201(4):275-84. PubMed ID: 2674532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma: the COSS experience.
    Bielack S; Jürgens H; Jundt G; Kevric M; Kühne T; Reichardt P; Zoubek A; Werner M; Winkelmann W; Kotz R
    Cancer Treat Res; 2009; 152():289-308. PubMed ID: 20213397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Goal and results of the COSS study].
    Flege S; Bielack S
    Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):282-8. PubMed ID: 15503258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS).
    Bielack SS; Wulff B; Delling G; Göbel U; Kotz R; Ritter J; Winkler K
    Med Pediatr Oncol; 1995 Jan; 24(1):6-12. PubMed ID: 7968796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
    Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
    Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of treatment in primary disseminated osteosarcoma. Analysis of the follow-up of patients in the cooperative osteosarcoma studies COSS-80 and COSS-82].
    Winkler K; Torggler S; Beron G; Bode U; Gerein V; Jürgens H; Kusnierz-Glaz C; Kotz R; Salzer-Kuntschik M; Schmoll HJ
    Onkologie; 1989 Apr; 12(2):92-6. PubMed ID: 2660050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group.
    Jasnau S; Meyer U; Potratz J; Jundt G; Kevric M; Joos UK; Jürgens H; Bielack SS;
    Oral Oncol; 2008 Mar; 44(3):286-94. PubMed ID: 17467326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96).
    Jäger M; Schultheis A; Westhoff B; Krauspe R
    Anticancer Res; 2005; 25(2A):947-54. PubMed ID: 15868932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8
    Fritzsching B; Fellenberg J; Moskovszky L; Sápi Z; Krenacs T; Machado I; Poeschl J; Lehner B; Szendrõi M; Bosch AL; Bernd L; Csóka M; Mechtersheimer G; Ewerbeck V; Kinscherf R; Kunz P
    Oncoimmunology; 2015 Mar; 4(3):e990800. PubMed ID: 25949908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate pharmacokinetics and prognosis in osteosarcoma.
    Graf N; Winkler K; Betlemovic M; Fuchs N; Bode U
    J Clin Oncol; 1994 Jul; 12(7):1443-51. PubMed ID: 8021736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
    Winkler K; Beron G; Delling G; Heise U; Kabisch H; Purfürst C; Berger J; Ritter J; Jürgens H; Gerein V
    J Clin Oncol; 1988 Feb; 6(2):329-37. PubMed ID: 2448428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of the COSS-77 and COSS-80 studies on adjuvant chemotherapy in osteosarcoma of the extremities].
    Purfürst C; Beron G; Torggler S; Kotz R; Salzer-Kuntschik M; Winkler K
    Klin Padiatr; 1985; 197(3):233-8. PubMed ID: 2409325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.